PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds tumor suppressor may actually fuel aggressive leukemia

2013-08-27
(Press-News.org) CINCINNATI – New research in the Journal of Clinical Investigation suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML).

Researchers from Cincinnati Children's Hospital Medical Center report their results in a study posted online Aug. 27 by the journal.

The protein scientists targeted is a transcription factor known as RUNX1, which also plays an important role in helping regulate the normal development of blood cells. The researchers were surprised to discover in their laboratory tests that RUNX1 was supporting the growth of AML fueled by what are called fusion proteins.

"RUNX1 is generally considered a tumor suppressor in myeloid neoplasms, but our study found that inhibiting its activity rather than enhancing it could be a promising therapeutic strategy for AMLs driven by fusion proteins," said James Mulloy PhD., a researcher in the Division of Experimental Hematology and Cancer Biology at Cincinnati Children's and lead investigator.

AML develops and progresses rapidly in patients, requiring prompt treatment with chemotherapy, radiation or bone marrow transplant. These treatments can be risky or only partially effective depending on the patient as well as the variation and progression of disease. Researchers like Mulloy are searching for improved treatment strategies, including targeted molecular approaches that could potentially be more effective and carry fewer side effects.

They tested this finding in a genetic mouse model of AML developed by Mulloy's laboratory that is driven by fusion proteins and a mixed-lineage leukemic gene called MLL-AF9. The researchers genetically inhibited both RUNX1 and an associated protein called core-binding factor subunit beta (Cbfb). By doing so, the researchers were able to stop the development of leukemia cells, demonstrating the potential viability of RUNX1 as a therapeutic target.

Also collaborating on the research was Paul Liu, MD, PhD, at the National Cancer Institute (National Institutes of Health), who developed a small molecule that specifically inhibits RUNX1. Using this inhibitor, the researchers showed that the AML cells were more sensitive than normal blood cells, indicating the inhibitor may be useful in the future as a therapy for patients with AML.

The research team continues to test inhibition of RUNX1 in AMLs driven by fusion proteins and in other blood disorders involving RUNX1. Their goal is to see how their findings might eventually lead to potential treatment of human disease.

### Funding support for the research came, in part, from the National Institutes of Health's National Center for Research Resources (1UL1RR026314-01), a U.S. Public Health Service Translational Trials Development and Support Laboratory award (MO1RR08084), CancerFreeKids Foundation for Cancer Research, the Intramural Research Program of the National Human Genome Research Institute, NIH (HG000030-18), a Cincinnati Children's Clinical and Translational Science Award and the Leukemia and Lymphoma Society.

About Cincinnati Children's: Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S. News and World Report's 2013 Best Children's Hospitals ranking. It is ranked #1 for cancer and in the top 10 for nine of 10 pediatric specialties. Cincinnati Children's, a non-profit organization, is one of the top two recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati College of Medicine. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at http://www.cincinnatichildrens.org. Connect on the Cincinnati Children's blog, via Facebook and on Twitter.


ELSE PRESS RELEASES FROM THIS DATE:

Study identifies molecular process behind form of non-syndromic deafness

2013-08-27
CINCINNATI – Researchers identify an underlying molecular process that causes a genetic form of non-syndromic deafness in a new study that also suggests affected families may be at risk of damage to other organs. A multi-national research team led by scientists at Cincinnati Children's Hospital Medical Center report their findings in a study posted online Aug. 27 by the Journal of Clinical Investigation. The research opens the door to finding possible treatments for the condition (called DFNB49 non-syndromic hearing loss) and points to possible cellular damage in other ...

Personalized AF management needed to close mortality gap

2013-08-27
Amsterdam, The Netherlands – Tuesday 27 August 2013: Personalised management is the only way to close the mortality gap for patients with atrial fibrillation (AF), according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK). The Atrial Fibrillation competence NETwork (AFNET) and European Heart Rhythm Association (EHRA) consensus paper is published online in the European Journal of Pacing, Arrhythmias, and Cardiac Electrophysiology (EP-Europace)1 and presented during the ESC Congress session on personalised cardiology. Professor ...

A genetic treasure hunting in sorghum may benefit crop improvement

2013-08-27
August 27, 2013, Shenzhen, China - A consortium of researchers from The University of Queensland, the Queensland Department of Agriculture, Fisheries and Forestry (DAFF Qld) and BGI has discovered that sorghum, a drought-tolerant African crop, holds vastly more genetic variation than previously reported. This study published in Nature Communications today provides an invaluable resource for the genetic improvement of sorghum and other grass species. Sorghum is not only a food and feed cereal crop, but also can be used as the basis of biofuel. Its resistance to heat and ...

Novel approach to gene regulation can activate multiple genes simultaneously

2013-08-27
CAMBRIDGE, Mass. (August 27, 2013) – By creating a powerful new gene regulation system called CRISPR-on, Whitehead Institute researchers now have the ability to increase the expression of multiple genes simultaneously and precisely manipulate each gene's expression level. The system is effective in both mouse and human cells as well as in mouse embryos. "CRISPR-on is a tool that will be very useful for studying many biological processes, particularly for studying gene functions and gene networks," says Whitehead Founding Member Rudolf Jaenisch. "In contrast to RNA interference, ...

European hunter-gatherers owned pigs as early as 4600BC

2013-08-27
European hunter-gatherers acquired domesticated pigs from nearby farmers as early as 4600BC, according to new evidence. The international team of scientists, including researchers at Durham and Aberdeen universities, showed there was interaction between the hunter-gatherer and farming communities and a 'sharing' of animals and knowledge. The interaction between the two groups eventually led to the hunter-gatherers incorporating farming and breeding of livestock into their culture, say the scientists. The research, published in Nature Communications today (27 August), ...

Long-term memory in the cortex

2013-08-27
'Where' and 'how' memories are encoded in a nervous system is one of the most challenging questions in biological research. The formation and recall of associative memories is essential for an independent life. The hippocampus has long been considered a centre in the brain for the long-term storage of spatial associations. Now, Mazahir T. Hasan at the Max Planck Institute for Medical Research and José Maria Delgado-Garcìa at the University Pablo de Olavide of Seville, Spain, were able to provide first experimental evidence that a specific form of memory associations is ...

Earthquakes and tectonics in Pamir Tien Shan

2013-08-27
Earthquake damage to buildings is mainly due to the existing shear waves which transfer their energy during an earthquake to the houses. These shear waves are significantly influenced by the underground and the topography of the surrounding area. Detailed knowledge of the landform and the near-surface underground structure is, therefore, an important prerequisite for a local seismic hazard assessment and for the evaluation of the ground-effect, which can strongly modify and increase local ground motion. As described in the latest issue of Geophysical Journal International, ...

Computer test reveals high prevalence of attention disorders in stroke patients

2013-08-27
A majority of stroke patients have problems paying attention and could be helped by brain-training computer games, a new study suggests. Researchers at Imperial College London found that problems such as difficulty filtering out distractions, difficulty following instructions, and reduced alertness are much more common in stroke patients than doctors realise. Their study, published in Neurology, showed that brain scans and bedside tests can be used to diagnose these three types of attention problems, each of which could be addressed with computer games tailored for the ...

Existence of new element confirmed

2013-08-27
An international team of researchers, led by physicists from Lund University, have confirmed the existence of what is considered a new element with atomic number 115. The experiment was conducted at the GSI research facility in Germany. The results confirm earlier measurements performed by research groups in Russia. "This was a very successful experiment and is one of the most important in the field in recent years", said Dirk Rudolph, Professor at the Division of Atomic Physics at Lund University. Besides the observations of the new chemical element, the researchers ...

New energy model offers transparency to let others replicate findings

2013-08-27
Computer models are used to inform policy decisions about energy, but existing models are generally "black boxes" that don't show how they work, making it impossible for anyone to replicate their findings. Researchers from North Carolina State University have developed a new open-source model and are sharing the data they put into it, to allow anyone to check their work – an important advance given the environmental and economic impact of energy policy decisions. "Most models show you the math behind how they work, but don't share the source code that is supposed to implement ...

LAST 30 PRESS RELEASES:

Weight-loss wonder pills prompt scrutiny of key ingredient

Nonprofit leader Diane Dodge to receive 2026 Penn Nursing Renfield Foundation Award for Global Women’s Health

Maternal smoking during pregnancy may be linked to higher blood pressure in children, NIH study finds

New Lund model aims to shorten the path to life-saving cell and gene therapies

Researchers create ultra-stretchable, liquid-repellent materials via laser ablation

Combining AI with OCT shows potential for detecting lipid-rich plaques in coronary arteries

SeaCast revolutionizes Mediterranean Sea forecasting with AI-powered speed and accuracy

JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health

Honey bees navigate more precisely than previously thought

Air pollution may directly contribute to Alzheimer’s disease

Study finds early imaging after pediatric UTIs may do more harm than good

UC San Diego Health joins national research for maternal-fetal care

New biomarker predicts chemotherapy response in triple-negative breast cancer

Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury

Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated

Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients

Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US

Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments

JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research

Classifying pediatric brain tumors by liquid biopsy using artificial intelligence

Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers

Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer

A “smart fluid” you can reconfigure with temperature

New research suggests myopia is driven by how we use our eyes indoors

Scientists develop first-of-its-kind antibody to block Epstein Barr virus

With the right prompts, AI chatbots analyze big data accurately

Leisure-time physical activity and cancer mortality among cancer survivors

Chronic kidney disease severity and risk of cognitive impairment

Research highlights from the first Multidisciplinary Radiopharmaceutical Therapy Symposium

New guidelines from NCCN detail fundamental differences in cancer in children compared to adults

[Press-News.org] Study finds tumor suppressor may actually fuel aggressive leukemia